| Biography | Gabe focuses his practice on all aspects of patent prosecution, including initial stages of patent application strategy and planning, application drafting and ex parte prosecution before the USPTO. He also has been involved in the counseling of a variety of biotechnology and pharmaceutical clients on the management and development of their patent portfolios. In addition, Gabe provides advice and counseling in due diligence projects by way of opinions as to patentability, freedom to operate, infringement and validity in connection with various transactions, litigation or other proceedings. He also has experience in interference proceedings before the USPTO, opposition proceedings in Europe, and litigation support in pharmaceutical drug patent disputes under the Hatch-Waxman Act. Notable Experience · Gabe has managed substantial intellectual property portfolios on behalf of academic institutions, small molecule pharmaceutical corporations, and emerging biotechnology companies both in the United States, Europe and in other countries around the world. · He has advised medical device companies, including one of the world's leading medical device manufacturers, on a variety of patent prosecution and due diligence patent issues involving the procurement of new patents, acquisition of new technologies, and patent challenges. · Gabe has obtained or has been involved in obtaining important US and foreign patents for a variety of biotechnology and pharmaceutical clients in a variety of technologies, including small molecule compounds, protein and nucleic acid therapeutics, diagnostic and drug screening assays, dyes, recombinant organisms, therapeutic antibodies, anti-viral technologies, drug delivery systems, stents and intravascular technologies, medical devices, and RNA interference. · He has performed extensive legal research and analysis of biotechnology and chemical patents for a variety of due diligence projects in connection with various financial transactions, litigations, oppositions and interferences before the USPTO. Recent Speaking Engagements and Publications · "Computers and the Law: Intellectual Property: Part One," co-author, Computer Magazine, Vol. 45, No. 1, January 12, 2012, pp. 14-16. · "Computers and the Law: Intellectual Property: Part One," speaker, Computer Magazine podcast, January 2012. · "Science Entrepreneurs Forum," panelist, Presented by the College of Natural Sciences, University of Massachusetts, Amherst, Massachusetts, November 3, 2011. · Centocor Ortho Biotech, Inc. v. Abbott Laboratories: Effect on the "antibody exception" to written description, Edwards Angell Palmer Dodge Intellectual Property Practice Group presentation, June 28, 2011. · McCool, "Solvay v. Honeywell: Discussion and Significance," Edwards Angell Palmer Dodge Intellectual Property Practice Group presentation (2010). · McCool, "Federal Rules of Evidence 502: One Year(+) Later," Edwards Angell Palmer Dodge Intellectual Property Practice Group presentation (2009). · McCool, "In re Kubin: is obvious to try the new standard for biotechnology inventions?" Edwards Angell Palmer Dodge IP Bulletin Summer/Fall Issue (2009). · McCool, "Friskit, Inc. v. RealNetworks, Inc.: a continued trend towards patent invalidation after KSR," Edwards Angell Palmer Dodge Intellectual Property Practice Group presentation (2009). · McCool et al., U.S. Patent No. 6,835,820, entitled "Polyhydroxyalkanoate biosynthesis associated proteins and coding region in Bacillus megaterium" (2004). · McCool et al., "PhaC and PhaR are required for polyhydroxyalkanoic acid synthesis in Bacillus megaterium, Journal of Bacteriology," 183: 4235-4243 (cover feature) (2001). · McCool, "Exploring the structure and function of FtsZ, a prokaryotic cell division protein and tubulin homologue," Presentation before the Department of Microbiology, University of Massachusetts Amherst, Amherst, MA (2001). · McCool, "Exploring the structure and function of FtsZ, a prokaryotic cell division protein and tubulin homologue," World Index of Macromolecular Visualization Resources, see (http://www.molvisindex.org) (2000). · McCool et al., "Polyhydroxyalkanoate inclusion-body associated proteins and coding region in Bacillus megaterium," Journal of Bacteriology (featured on cover) 181: 85-92 (1999). · McCool et al., "Localization of PhaP and PhaC to PHA inclusion-bodies in living cells of Bacillus megaterium," Invited Student Seminar and poster presented at the 99th General Meeting of the American Society for Microbiology, Chicago, IL (1999). · McCool et al., "Identification and characterization of the phaBC locus from Bacillus megaterium," Poster presented at the 97th General meeting of the American Society for Microbiology, Miami, FL (1997). · McCool et al., "Polyhydroxyalkanoate inclusion-body growth and proliferation in Bacillus megaterium," FEM Microbiology Letters 137: 41-48 (1996). News & Publications January 2012, In Article and Podcast, Edwards Wildman Team Provides IP Primer for Computer Magazine Fall 2009, Intellectual Property Bulletin - Fall 2009 Fall 2009, "Obvious to Try": A New Standard for Biotechnology Inventions? Industries · Life Sciences Memberships · Advisory Board, College of Natural Sciences, University of Massachusetts, Amherst, Massachusetts |